cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Sutro Biopharma Inc
2 own
6 watching
Current Price
$1.84
$-0.01
(-0.54%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
406.54M
52-Week High
52-Week High
6.13000
52-Week Low
52-Week Low
1.70000
Average Volume
Average Volume
0.78M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization406.54M
icon52-Week High6.13000
icon52-Week Low1.70000
iconAverage Volume0.78M
iconDividend Yield--
iconP/E Ratio--
What does the Sutro Biopharma Inc do?
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company s product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Read More
How much money does Sutro Biopharma Inc make?
News & Events about Sutro Biopharma Inc.
Globe Newswire
1 year ago
- Sutro will receive $140 million upfront and is eligible to receive up to an additional $250 million in future milestone payments in exchange for the royalty, or revenue interest, in potential future sales of Vaxcytes products - - Transaction provides non-dilutive growth capital to Sutro for ...
Globe Newswire
1 year ago
ORLANDO, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced expanded preclinical data for STRO-003, its ROR1 targeting ADC, ...
Globe Newswire
1 year ago
SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will ...
Ticker Report
1 year ago
Sutro Biopharma (NASDAQ:STRO Get Rating) had its price objective lifted by research analysts at Piper Sandler from $16.00 to $18.00 in a research report issued to clients and investors on Tuesday, The Fly reports. The brokerage presently has an overweight rating on the stock. ...
Globe Newswire
1 year ago
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will ...
Frequently Asked Questions
Frequently Asked Questions
What is Sutro Biopharma Inc share price today?
plus_minus_icon
Can Indians buy Sutro Biopharma Inc shares?
plus_minus_icon
How can I buy Sutro Biopharma Inc shares from India?
plus_minus_icon
Can Fractional shares of Sutro Biopharma Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Sutro Biopharma Inc stocks?
plus_minus_icon
What is today’s traded volume of Sutro Biopharma Inc?
plus_minus_icon
What is today’s market capitalisation of Sutro Biopharma Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Sutro Biopharma Inc?
plus_minus_icon
What percentage is Sutro Biopharma Inc down from its 52-Week High?
plus_minus_icon
What percentage is Sutro Biopharma Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.84
$-0.01
(-0.54%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
ALX ONCOLOGY HOLDINGS INC
ALX ONCOLOGY HOLDINGS INC
$1.67
$0.01 (0.60 %)
Fulcrum Therapeutics Inc
Fulcrum Therapeutics Inc
$4.70
$0.02 (0.43 %)
Cullinan Oncology Inc
Cullinan Oncology Inc
$12.18
$-0.02 (-0.16 %)
Chemomab Therapeutics Ltd
Chemomab Therapeutics Ltd
$1.81
$-0.21 (-10.40 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
ALX ONCOLOGY HOLDINGS INC
ALX ONCOLOGY HOLDINGS INC
$1.67
$0.01 (0.60 %)
Fulcrum Therapeutics Inc
Fulcrum Therapeutics Inc
$4.70
$0.02 (0.43 %)
Cullinan Oncology Inc
Cullinan Oncology Inc
$12.18
$-0.02 (-0.16 %)
Chemomab Therapeutics Ltd
Chemomab Therapeutics Ltd
$1.81
$-0.21 (-10.40 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00